Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Inflammation
Interventions
DRUG

Ketorolac 0.4%

One drop 4 times a day in the pre-operative eye beginning day 0 for 4 days

DRUG

Lubricating Eye Drop

One drop 4 times a day in the operative eye beginning one day prior to the peripheral iridotomy and continuing until the day of IOL implantation

Trial Locations (1)

Unknown

Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00791323 - Efficacy of Ketorolac 0.4% in Prostaglandin Suppression | Biotech Hunter | Biotech Hunter